Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Mar 27, 2015; 7(3): 33-38
Published online Mar 27, 2015. doi: 10.4240/wjgs.v7.i3.33
Published online Mar 27, 2015. doi: 10.4240/wjgs.v7.i3.33
Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study
Simeon Niyi Babawale, Thomas Mandøe Jensen, Jens Brøndum Frøkjær, Department of Radiology, Aalborg University Hospital, DK-9000 Aalborg, Denmark
Jens Brøndum Frøkjær, Department of Clinical Medicine, Aalborg University, DK-9000 Aalborg, Denmark
Author contributions: Babawale SN analysed the data and prepared the manuscript; Jensen TM contributed to the conduct of the study; Frøkjær JB participated in the study design and contributed to manuscript preparation.
Supported by Department of Radiology, Aalborg University Hospital, Aalborg, Denmark.
Ethics approval: N/A.
Informed consent: N/A.
Conflict-of-interest: None.
Data sharing: Raw dataset is available from the corresponding author at jebf@rn.dk.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jens Brøndum Frøkjær, MD, PhD, Associate Professor, Department of Radiology, Aalborg University Hospital, Hobrovej 18-22, DK-9000 Aalborg, Denmark. jebf@rn.dk
Telephone: +45-97-665105 Fax: +45-99-326507
Received: September 11, 2014
Peer-review started: September 12, 2014
First decision: November 27, 2014
Revised: January 8, 2015
Accepted: January 18, 2015
Article in press: January 20, 2015
Published online: March 27, 2015
Peer-review started: September 12, 2014
First decision: November 27, 2014
Revised: January 8, 2015
Accepted: January 18, 2015
Article in press: January 20, 2015
Published online: March 27, 2015
Core Tip
Core tip: The current study corroborates the consensus in the literature which proposes that adequate patients’ selection before radiofrequency ablation (RFA) therapy is vitally important to achieving a satisfactory ablation success. To the best of our knowledge, the consensus proposed that patients with more than 5 hepatic metastases and tumour size of more than 40 mm are probably unsuitable for RFA. Furthermore, inadvertent inclusion of patients with extra-hepatic metastases for RFA treatment of colorectal liver metastases is an important factor that can influence negatively the overall patients’ survival.